NASDAQ: CRDF
Cardiff Oncology Inc Stock Ownership - Who owns Cardiff Oncology?

Insider buying vs selling

Have Cardiff Oncology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mani MohindruCEO2026-07-1434,364$1.46
$50.00kBuy
Gary W. PaceDirector2026-07-14687,285$1.46
$1,000.00kBuy
Mani MohindruChief Executive Officer2026-06-1824,703$1.21
$29.89kBuy
Gary W. PaceDirector2026-06-1830,000$1.22
$36.60kBuy

1 of 1

CRDF insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRDF insiders and whales buy or sell their stock.

CRDF Shareholders

What type of owners hold Cardiff Oncology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Robert Merrill Hunter6.51%5,065,004$6.08MInsider
Gary W. Pace4.93%3,837,098$4.60MInsider
Ra Capital Management LP4.23%3,290,000$3.95MInsider
Bridger Management LLC3.82%2,968,115$3.56MInsider
Kira Sheinerman1.17%909,090$1.09MInsider
William J. Welch1.08%842,645$1.01MInsider
Gabriel Cerrone0.93%725,776$870.93kInsider
James E. Levine0.16%127,716$153.26kInsider
Lale White0.15%113,788$136.55kInsider
Steve Zaniboni0.12%96,968$116.36kInsider

1 of 3

CRDF vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRDF0.02%23.54%Net BuyingNet Buying
CGTX0.02%28.70%Net Selling
BMEA0.03%25.13%Net Buying
RLYB0.01%99.99%Net BuyingNet Buying
ICCC0.01%21.31%Net Buying

Cardiff Oncology Stock Ownership FAQ

Who owns Cardiff Oncology?

Cardiff Oncology (NASDAQ: CRDF) is owned by 0.02% institutional shareholders, 23.54% Cardiff Oncology insiders, and 76.44% retail investors. Robert Merrill Hunter is the largest individual Cardiff Oncology shareholder, owning 5.07M shares representing 6.51% of the company. Robert Merrill Hunter's Cardiff Oncology shares are currently valued at $5.93M.

If you're new to stock investing, here's how to buy Cardiff Oncology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.